カリフォルニア州における潰瘍性大腸炎の臨床試験
カリフォルニア州内の拠点で、潰瘍性大腸炎に関する40件の研究が参加者を募集しています。
カリフォルニア州内の都市
- San Diego15件の研究
- Los Angeles13件の研究
- Lancaster8件の研究
- Mountain View8件の研究
- Anaheim7件の研究
- Westminster5件の研究
- San Francisco4件の研究
- Victorville4件の研究
- Thousand Oaks3件の研究
- Oxnard3件の研究
- Murrieta3件の研究
- Newport Beach3件の研究
- Folsom3件の研究
- Garden Grove3件の研究
- San Bernardino3件の研究
- Sacramento3件の研究
- Chula Vista3件の研究
- Orange3件の研究
公式研究テキスト（英語）
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Clinnova Research /ID# 280509, Anaheim
- Southern California Res. Ctr /ID# 280476, Coronado
- Gastro Care Institute /ID# 281071, Lancaster
- 他2件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/10/01更新 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology and Liver Institute, Escondido
- United Clinical Research Institute, Murrieta
被験者募集中第4相
18歳〜80歳 · 全性別 · 2026/09/30更新 · NCT06581328A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
- Rady Children's Hospital /ID# 271873, San Diego
- University of California San Francisco - Mission Bay /ID# 273022, San Francisco
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/09/30更新 · NCT07071519A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Erick Alayo Medical Corp/Gastro SB Clinic, Chula Vista
- Southern California GI and Liver Centers (SCLC), Coronado
- Valley View Research, Garden Grove
- 他6件
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/30更新 · NCT06598943Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Palo Alto
被験者募集中第1/2相健康なボランティア歓迎
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT06619990A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
- Site 024, Canoga Park
- Site 023, La Jolla
- Site 012, Lancaster
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07012395A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-018, San Diego
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/29更新 · NCT07845487A Study to Evaluate Efficacy and Safety of MK-8690 in Participants With Moderately to Severely Active Ulcerative Colitis (MK-8690-002)
- Clinnova Research ( Site 1042), Anaheim
- Southern California Research Center ( Site 1044), Coronado
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/09/28更新 · NCT07463183A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- Gastro Care Institute, Lancaster
- Medical Associates Research Group, Inc., San Diego
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT06979336A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Clinnova Research, Anaheim
- Southern California Research Center, Coronado
- Om Research LLC, Lancaster
- 他7件
被験者募集中第3相
12歳以上 · 全性別 · 2026/09/25更新 · NCT07196748A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
- Loma Linda University Health System, Loma Linda
- Cedars-Sinai Medical Center, Los Angeles
- Lucile Packard Children's Hospital, Palo Alto
- 他1件
被験者募集中第2/3相
2歳〜17歳 · 全性別 · 2026/09/24更新 · NCT05076175Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Smart Cures Clinical Research, Anaheim
- Cedars-Sinai Medical Center, Beverly Hills
- United Medical Doctors - Los Alamitos, Los Alamitos
- 他1件
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/23更新 · NCT03816345A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
- Biopharma Informatic, LLC, Los Angeles
- Om Research LLC, Oxnard
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07483073A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- UCSF Medical Center at Mission Bay, San Francisco
被験者募集中第3相
2歳〜19歳 · 全性別 · 2026/09/22更新 · NCT04844606LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Clinnova Research - Anaheim, Anaheim
- Om Research LLC, Lancaster
- Biopharma Informatic, LLC, Los Angeles
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07186101LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Clinnova Research, Anaheim
- GMC Clinical Research, Folsom
- Om Research LLC, Temple City
- 他1件
被験者募集中第2相
18歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07415044A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
- Cedars-Sinai Medical Center, Los Angeles
- Hoag Hospital Newport Beach, Newport Beach
被験者募集中第4相
18歳〜65歳 · 全性別 · 2026/09/21更新 · NCT06095128A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Southern California GI & Liver Centers - Site Number: 8400062, Coronado
- United Medical Doctors CA - Site Number: 8400044, Murrieta
- Om Research, LLC - Victorville - Site Number: 8400022, Victorville
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07185009A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
- Clinnova Research, Anaheim
- Gastro SB Clinic, Chula Vista
- United Medical Doctors, Los Alamitos
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/28更新 · NCT07577856An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- FOMAT - Unio Specialty Care Arcadia - Site Number: 8400027, Arcadia
- Alliance Research Institute - Site Number: 8400008, Canoga Park
- Southern California GI & Liver Centers - Site Number: 8400062, Coronado
- 他13件
被験者募集中第3相
16歳〜80歳 · 全性別 · 2026/08/20更新 · NCT07184996Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis
- Vanda Investigational Site, Chula Vista
被験者募集中第3相
18歳〜75歳 · 全性別 · 2026/08/18更新 · NCT07686081Functional Outcomes in Ulcerative Colitis Patients With Ileal Pouch Anal Anastomosis Treated With High Intensity Focused Electromagnetic Stimulation
- Cedars Sinai Medical Center, Los Angeles
被験者募集中
18歳以上 · 全性別 · 2026/08/12更新 · NCT07034443Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission
- Hoag Hospital, Irvine
- UC San Diego Health, La Jolla
- Cedars-Sinai, Los Angeles
- 他1件
被験者募集中
18歳以上 · 全性別 · 2026/08/07更新 · NCT05230173BOOM-IBD2 Pivotal Clinical Trial
- Gastroenterology Medical Clinic (Objective Health), Folsom
- Center for Colorectal Innovation, Los Angeles
- Hoag Hospital, Newport Beach
- 他1件
被験者募集中
18歳〜85歳 · 全性別 · 2026/08/06更新 · NCT06571669A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Children's Hospital Of Orange County, Orange
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/08/03更新 · NCT06100289An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
- Scripps Clinic Torrey Pines, La Jolla
- United Medical Doctors, Los Alamitos
- United Medical Doctors, Los Alamitos
被験者募集中観察研究
18歳〜64歳 · 全性別 · 2026/07/09更新 · NCT06398626A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis
- Valley View Wellness Medical Center, Garden Grove
- Loma Linda Children's Hospital, Loma Linda
- Loma Linda University Clinical Trial Center, Loma Linda
- 他7件
被験者募集中第2相
12歳〜17歳 · 全性別 · 2026/07/08更新 · NCT05287126A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Loma Linda University, Loma Linda
- Children's Hospital of Orange County, Orange
- Stanford Children's Health, Palo Alto
被験者募集中第3相
2歳〜17歳 · 全性別 · 2026/06/22更新 · NCT06405087R-3750 in Patients With Mild to Moderate Ulcerative Colitis
- Amicis Research Center, Valencia
被験者募集中第1相
18歳〜65歳 · 全性別 · 2026/06/12更新 · NCT05666960The Use of Butyrate Therapy in Pediatric Ulcerative Colitis
- Children's Hospital Los Angeles, Los Angeles
被験者募集中第2相
7歳〜21歳 · 全性別 · 2026/06/04更新 · NCT05218850A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Rady Children's Hospital - San Diego - PIN, San Diego
被験者募集中第3相
2歳以上 · 全性別 · 2026/05/07更新 · NCT05442567A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis
- Investigational Site Number: 8400009, Escondido
- Investigational Site Number: 8400006, Lancaster
- Investigational Site Number: 8400025, Thousand Oaks
被験者募集中第2相
18歳〜75歳 · 全性別 · 2026/04/23更新 · NCT06975722Fermented Food-Supplemented Diet in Ulcerative Colitis
- Stanford University, Palo Alto
被験者募集中
18歳以上 · 全性別 · 2026/02/27更新 · NCT04401605The Influence of a Fasting Mimicking Diet on Ulcerative Colitis
- Stanford University, Palo Alto
被験者募集中
18歳〜70歳 · 全性別 · 2026/02/27更新 · NCT03615690Impact of Prebiotics in Ulcerative Colitis
- UCLA, Los Angeles
被験者募集中
18歳〜85歳 · 全性別 · 2026/02/27更新 · NCT06495658Hyperbaric Oxygen Therapy for Ulcerative Colitis (HBOT-UC)
- University of Los Angeles Health, Los Angeles
被験者募集中
18歳〜85歳 · 全性別 · 2026/01/08更新 · NCT05987852Effects of Pomegranate Juice on Ulcerative Colitis
- West Los Angeles VA Medical Center, Los Angeles
- UCLA Center for Human Nutrition, Los Angeles
被験者募集中
18歳以上 · 全性別 · 2025/12/09更新 · NCT07115862Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis
- Bausch Health Site 008, Garden Grove
被験者募集中第4相
5歳〜17歳 · 全性別 · 2025/09/16更新 · NCT04314375Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients
- University of California San Diego, La Jolla
被験者募集中第2相
18歳〜80歳 · 全性別 · 2023/05/16更新 · NCT04721873ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。